Hi-tech Pharmacal Co, Inc. (HITK) Tops Q2 EPS by 27c, Sales Exceed Expectations

Hi-tech Pharmacal Co, Inc. (NASDAQ: HITK) reported Q2 EPS of $1.04, $0.27 better than the analyst estimate of $0.77. Revenue for the quarter came in at $56.88 million versus the consensus estimate of $51.4 million.

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• Blackhawk Network (HAWK) Reports Q2 Loss of $0.07; Offers Guidance
• Newton Golf Company (NWTG) Reports Q2 Loss of $0.49
• Hydrofarm Holdings Group, Inc. (HYFM) Misses Q2 EPS by 134c